Molecular medicine review reveals the role of IGF in cancer, other proliferative diseases – Phys.org

Click here to sign in with or
Forget Password?
Learn more
share this!
1
4
Share
Email
August 31, 2022
by Sbarro Health Research Organization (SHRO)
Studies suggest that Insulin-Like Growth Factor (IGF) plays a central role in pathological growth of proliferative conditions like cancer, and may function as a resistance mechanism adopted by the majority of solid cancers following therapeutic targeting of non-IGF signaling pathways.
Last week, the journal Cell Cycle published the review article titled “Cell Cycle Control by the Insulin-like Growth Factor Signal: At the Crossroad between Cell Growth and Mitotic Regulation.” The work comes from the longstanding expertise and collaboration of the co-authors affiliated with the ISOPROG-Somatolink Research Network and the Sbarro Institute for Cancer Research and Molecular Medicine, part of the Sbarro Health Research Organization (SHRO), at Temple University in Philadelphia, along with the Arthur Riggs Diabetes Institute and Beckmann Research Institute at City of Hope in Duarte, California.
According to the authors, “The article has been specifically designed both for newcomers in the IGF biology field as well as to established researchers focusing on pathway-driven molecular targeting.
“Overall, the review aims to clarify and functionally connect established experimental findings and re-directs readers on extensively validated research on this complex molecular system and its growth/mitotic cellular network.
“Analysis suggests that IGF signal co-targeting strategies and solutions still represent an unmet objective in current pathway-driven cancer therapeutics. Consequently, a better understanding of the IGF growth/mitotic-regulatory signal remains a key goal towards more effective cancer therapies.”
More information: Pierluigi Scalia et al, Cell cycle control by the insulin-like growth factor signal: at the crossroad between cell growth and mitotic regulation, Cell Cycle (2022). DOI: 10.1080/15384101.2022.2108117

Journal information: Cell Cycle
Provided by Sbarro Health Research Organization (SHRO)
Explore further
Facebook
Twitter
Email
Feedback to editors
18 hours ago
0
Feb 2, 2024
1
Feb 2, 2024
0
Feb 2, 2024
0
Feb 1, 2024
0
17 hours ago
18 hours ago
Feb 2, 2024
Feb 2, 2024
Feb 2, 2024
Feb 2, 2024
Feb 2, 2024
Feb 2, 2024
Feb 2, 2024
Feb 2, 2024
2 hours ago
23 hours ago
Feb 2, 2024
Jan 28, 2024
Jan 23, 2024
Jan 23, 2024
More from Biology and Medical
Aug 16, 2021
Jul 13, 2021
Jul 28, 2022
Aug 9, 2021
Mar 3, 2022
May 27, 2022
Feb 2, 2024
Feb 2, 2024
Feb 2, 2024
Feb 2, 2024
Feb 2, 2024
Feb 2, 2024
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Phys.org in any form.

Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we’ll never share your details to third parties.
More information Privacy policy
We keep our content available to everyone. Consider supporting Science X’s mission by getting a premium account.
Medical research advances and health news
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web

source

About The Author

admin

See author's posts